Endpoints has grown to become the daily habit of biopharma pros from the C-suite to the bench since its founding 10 years ago. Join founder and CEO Arsalan Arif for a live virtual Q&A, and get an inside look into our 2026 plans and how that might align with your brand. 

We know you’re busy for the year ahead, and so this session is strictly for communications specialists and focuses on strategies to help achieve business goals.

We’ll cover:

• Major editorial themes for 2026 and how we’re building on our award-winning journalism
• New platform upgrades coming in 2026 
• What that means for your brand and lead-gen goals
• Market and brand research possibilities with our new Endpoints Signal division 
• … and any other questions you have during our live Q&A